ANDERSON CYNTHIA LYNN (CHIEF FINANCIAL OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/2/2024ACC: 0001415889-24-019024
Officer· CHIEF FINANCIAL OFFICER
Since Aug 2023
+3.59K
Net shares
Net buyer
$10.6K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
3.59K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.59K
Price / share
$2.96
Trade value
$10.63K
% of position
New position
6/28/2024
0.00→3.59K
Total
Net shares
+3.59K
Net value
$10.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/28/2024 | A · Award | +3.59K | $2.96 | $10.63K | New position | 0.00 | 3.59K |
| Total | +3.59K | $10.63K | ||||||
Derivative Transactions0
No derivative transactions reported